ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 249

MiR-204-3p Associates with an Increased Level of IL-6 in Familial Mediterranean Fever By Targeting the PIK3 Signaling Pathway

Tomohiro Koga1, Kiyoshi Migita2, Akihiro Yachie3, Yukitaka Ueki4, Kazunaga Agematsu5, Junya Masumoto6, Koh-ichiro Yoshiura7, Katsumi Eguchi8 and Atsushi Kawakami1, 1Unit of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 2Department of Rheumatology and Clinical Research Center, Nagasaki Medical Center, Omura, Japan, 3Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan, 4Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital, Sasebo, Japan, 5Department of Infectious Immunology, Shinshu University, Graduate School of Medicine, Shinshu, Japan, 6Department of Pathology, Division of Analyticalpathology, Ehime University Graduate School of Medicine, Toon, Japan, 7Department of Human Genetics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 8Department of Rheumatology and Metabolism, Sasebo City General Hospital, Sasebo, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: IL-6, MicroRNA and familial Mediterranean fever

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Miscellaneous Rheumatic and Inflammatory Diseases - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Familial Mediterranean fever (FMF) is caused by a number of mutations of the MEFV gene, coding for a protein named pyrin that acts as a major regulatory component of the inflammasome. Accumulating evidence has shown the association of microRNAs (miRNAs) with the development of inflammatory disorders (1). However, little is known about the precise role of miRNAs in FMF. Objective: The aim of this study was to identify a serum miRNAs profile and potential biomarkers in FMF and clarify their gene targets for understanding the pathogenesis of autoinflammatory diseases.

Methods: We performed miRNA microarray (Toray 3D-gene miRNA oligo chips) to screen miRNAs in the serum from FMF in attack and in remission. We subsequently examined the effect of candidate miRNAs on cytokine production by using THP-1 cells. Macrophages derived from THP-1 cells were transfected with miRNA mimics or miRNA inhibitor and stimulated with LPS+ATP for 24 hours. We collected the supernatants for the quantification of inflammatory cytokine production. To identify the target genes, we overexpressed its miRNA and performed Agilent expression microarray (SurePrint G3 Human GE 8x60K).

Results: We found that miR-204-3p was greatly decreased in the serum from FMF patients in attack. In vitro study, the expression of miR-204-3p was suppressed by ATP+LPS stimulation in macrophages derived from THP-1 cells. Inhibition of miR-204-3p significantly induced the production of IL-6 whereas overexpression of miR-204-3p inhibited its production. Bioinformatic analysis showed that miR-204-3p is predicted to target genes implicated in Toll like receptor pathway through regulation of PIK3 signaling.

Conclusion: These data suggest that serum miR-204-3p has a potential as a useful biomarker among patients with FMF and that miR-204-3p plays a critical role as a suppressor to regulate the production of IL-6 by targeting PIK3 signaling pathway. References:

1.     Singh RP, Massachi I, Manickavel S, et al. The role of miRNA in inflammation and autoimmunity. Autoimmun Rev. 2013 Oct;12(12):1160-5. Acknowledgements: This work was supported by the Japan Agency for Medical Research and Development (No. 15657398). à–¾: miRNA LPS IL-6 TNF.tif


Disclosure: T. Koga, None; K. Migita, None; A. Yachie, None; Y. Ueki, None; K. Agematsu, None; J. Masumoto, None; K. I. Yoshiura, None; K. Eguchi, UCB Pharma, 5; A. Kawakami, None.

To cite this abstract in AMA style:

Koga T, Migita K, Yachie A, Ueki Y, Agematsu K, Masumoto J, Yoshiura KI, Eguchi K, Kawakami A. MiR-204-3p Associates with an Increased Level of IL-6 in Familial Mediterranean Fever By Targeting the PIK3 Signaling Pathway [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/mir-204-3p-associates-with-an-increased-level-of-il-6-in-familial-mediterranean-fever-by-targeting-the-pik3-signaling-pathway/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mir-204-3p-associates-with-an-increased-level-of-il-6-in-familial-mediterranean-fever-by-targeting-the-pik3-signaling-pathway/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology